A variety of experimental myocardial molecular alterations have suggested that genetic therapies may impact on cardiac disease (24,34,35). Vascular growth factor genes may serve in the treatment of coronary artery disease or ischemic cardiomyopathy (29,45,46). States of left ventricular dysfunction or heart failure (HF) can be ameliorated with exogenous genes which alter the native #-adrenergic receptor (AR) system or which improve myocardial calcium handling(24,34,37). However, in order to utilize such genetic strategies to treat cardiac disease, safe and efficient methods for cardiac gene delivery must be developed. Importantly, to achieve alterations of heart function or structure, efficient gene delivery methods must be developed to transfect a majority of themyocardium. In this proposal, we investigate myocardial gene transfer in adult swine models employing cardiac surgery. The primary components of modem cardiac surgery include cardiopulmonary bypass (CPB), cardioplegic arrest and crossclamping of the ascending aorta. These steps may facilitate safer gene delivery since they result in an interruption of the coronary Circulation and an isolation of the coronary circulation from the systemic circulation, making """"""""cardioselective"""""""" gene transfer possible.The central hypothesis is that global myocardial transgene expression and secondary functional changes can be achieve in adult swine utilizing adenoviral delivery during simulated cardiac surgery.
The specific aims are: 1. Achieve safe and efficient myocardial gene transfer in adult pigs utilizing adenoviral and advanced generation vectors, delivered during simulated cardiac surgery. 2. Characterize post-cardiac surgery left ventricular dysfunction in adult pigs :and :reverse the dysfunction with betaAR based gene therapy delivered during the surgery. 3. Employ functional transgenes to achieve positive inotropic effects in a swine pacing heart failure model. i. Study inotropic effects of transgenes in cultured LV myocytes from failing pig hearts. ii. Deliver functional transgenes to failing pig hearts during simulated cardiac surgery and evaluate effect on LV performance. These studies will help to develop safer and more efficient methods for gene delivery which can be coupled to cardiac surgery. As our knowledge advances, gene therapy may supplement established surgical treatments.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL072183-02
Application #
6777046
Study Section
Surgery and Bioengineering Study Section (SB)
Program Officer
Lundberg, Martha
Project Start
2003-08-01
Project End
2007-07-31
Budget Start
2004-08-01
Budget End
2005-07-31
Support Year
2
Fiscal Year
2004
Total Cost
$385,000
Indirect Cost
Name
Duke University
Department
Surgery
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Piacentino 3rd, Valentino; Milano, Carmelo A; Bolanos, Michael et al. (2012) X-linked inhibitor of apoptosis protein-mediated attenuation of apoptosis, using a novel cardiac-enhanced adeno-associated viral vector. Hum Gene Ther 23:635-46
Perrino, Cinzia; Schroder, Jacob N; Lima, Brian et al. (2007) Dynamic regulation of phosphoinositide 3-kinase-gamma activity and beta-adrenergic receptor trafficking in end-stage human heart failure. Circulation 116:2571-9
Hata, Jonathan A; Williams, Matthew L; Schroder, Jacob N et al. (2006) Lymphocyte levels of GRK2 (betaARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved beta-adrenergic signaling after mechanical unloading. J Card Fail 12:360-8
Petrofski, Jason A; Hata, Jonathan A; Williams, Matthew L et al. (2005) A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts. J Thorac Cardiovasc Surg 130:1683-90
Perrino, Cinzia; Naga Prasad, Sathyamangla V; Schroder, Jacob N et al. (2005) Restoration of beta-adrenergic receptor signaling and contractile function in heart failure by disruption of the betaARK1/phosphoinositide 3-kinase complex. Circulation 111:2579-87
Hata, Jonathan A; Petrofski, Jason A; Schroder, Jacob N et al. (2005) Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts. J Thorac Cardiovasc Surg 129:1405-13
Williams, Matthew L; Hata, Jonathan A; Schroder, Jacob et al. (2004) Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts. Circulation 109:1590-3